CAMBRIDGE, Mass.—Jeremy Liew, 31 years old, moved to Boston from New Jersey in 2018 to study for a Ph.D. in chemistry and, he hoped, a career in the city’s bustling biotech industry. But after earning ...

Although it looked to be lights out for InflaRx’s C5a antibody vilobelimab in the rare skin disorder pyoderma gangrenosum (PG) last year, the German drugmaker ended 2025 with a glimmer of hope for the ...